MSC Fundamental Analysis - STUDIO CITY INTERNATIONA-ADR

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to MSC. MSC was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. MSC has a bad profitability rating. Also its financial health evaluation is rather negative. MSC does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

MSC had negative earnings in the past year.

MSC had negative earnings in each of the past 5 years.

In the past 5 years MSC reported 4 times negative operating cash flow.

1.2 Ratios

MSC has a Return On Assets of -2.34%. This is in the lower half of the industry: MSC underperforms 71.97% of its industry peers.

The Return On Equity of MSC (-12.85%) is comparable to the rest of the industry.

MSC's Return On Invested Capital of 1.66% is on the low side compared to the rest of the industry. MSC is outperformed by 71.21% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.34%
ROE	-12.85%
ROIC	1.66%

ROA(3y)-5.48%

ROA(5y)-6.93%

ROE(3y)-25.73%

ROE(5y)-27.91%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MSC has a Operating Margin (8.40%) which is in line with its industry peers.

MSC's Operating Margin has declined in the last couple of years.

Looking at the Gross Margin, with a value of 65.95%, MSC belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.

MSC's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	8.4%
PM (TTM)	N/A
GM	65.95%

OM growth 3YN/A

OM growth 5Y-26.8%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y31.47%

GM growth 5Y-3.57%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MSC is destroying value.

MSC has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, MSC has more shares outstanding

MSC has a worse debt/assets ratio than last year.

2.2 Solvency

MSC has an Altman-Z score of -0.47. This is a bad value and indicates that MSC is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of MSC (-0.47) is worse than 84.85% of its industry peers.

MSC has a Debt/Equity ratio of 3.97. This is a high value indicating a heavy dependency on external financing.

The Debt to Equity ratio of MSC (3.97) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	3.97
Debt/FCF	N/A
Altman-Z	-0.47

ROIC/WACC0.23

WACC7.12%

2.3 Liquidity

A Current Ratio of 0.96 indicates that MSC may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.96, MSC is in line with its industry, outperforming 52.27% of the companies in the same industry.

A Quick Ratio of 0.93 indicates that MSC may have some problems paying its short term obligations.

MSC has a Quick ratio of 0.93. This is comparable to the rest of the industry: MSC outperforms 51.52% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.96
Quick Ratio	0.93

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MSC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.

Looking at the last year, MSC shows a quite strong growth in Revenue. The Revenue has grown by 15.07% in the last year.

The Revenue has been growing slightly by 0.39% on average over the past years.

EPS 1Y (TTM)25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)15.07%

Revenue growth 3Y81.52%

Revenue growth 5Y0.39%

Sales Q2Q%17.65%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y53.13%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year16.73%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MSC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MSC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

60.61% of the companies in the same industry are more expensive than MSC, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	10.67

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MSC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

STUDIO CITY INTERNATIONA-ADR

NYSE:MSC (11/26/2025, 8:04:00 PM)

3.28

-0.19 (-5.44%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryHotels, Restaurants & Leisure

Earnings (Last)11-06 2025-11-06

Earnings (Next)02-27 2026-02-27/bmo

Inst Owners20.42%

Inst Owner Change-0.19%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap631.69M

Revenue(TTM)679.49M

Net Income(TTM)-68.47M

Analysts80

Price TargetN/A

Short Float %0.01%

Short Ratio0.19

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.93
P/FCF	N/A
P/OCF	N/A
P/B	1.19
P/tB	1.19
EV/EBITDA	10.67

EPS(TTM)-0.36

EYN/A

EPS(NY)-0.05

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS3.53

BVpS2.77

TBVpS2.77

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.34%
ROE	-12.85%
ROCE	2.1%
ROIC	1.66%
ROICexc	1.66%
ROICexgc	1.66%
OM	8.4%
PM (TTM)	N/A
GM	65.95%
FCFM	N/A

ROA(3y)-5.48%

ROA(5y)-6.93%

ROE(3y)-25.73%

ROE(5y)-27.91%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5Y-28.44%

ROICexc growth 3YN/A

ROICexc growth 5Y-28.63%

OM growth 3YN/A

OM growth 5Y-26.8%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y31.47%

GM growth 5Y-3.57%

F-ScoreN/A

Asset Turnover0.23

Health

		Industry Rank	Sector Rank
Debt/Equity	3.97
Debt/FCF	N/A
Debt/EBITDA	8.06
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.96
Quick Ratio	0.93
Altman-Z	-0.47

F-ScoreN/A

WACC7.12%

ROIC/WACC0.23

Cap/Depr(3y)169.85%

Cap/Depr(5y)190.59%

Cap/Sales(3y)1323.37%

Cap/Sales(5y)952.15%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

EPS Next Y53.13%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)15.07%

Revenue growth 3Y81.52%

Revenue growth 5Y0.39%

Sales Q2Q%17.65%

Revenue Next Year16.73%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y60.4%

EBIT growth 3YN/A

EBIT growth 5Y-26.51%

EBIT Next Year344.97%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y139.64%

FCF growth 3YN/A

FCF growth 5Y-13.68%

OCF growth 1Y1105.08%

OCF growth 3YN/A

OCF growth 5Y-3.63%

STUDIO CITY INTERNATIONA-ADR / MSC FAQ

What is the fundamental rating for MSC stock?

ChartMill assigns a fundamental rating of 1 / 10 to MSC.

What is the valuation status of STUDIO CITY INTERNATIONA-ADR (MSC) stock?

ChartMill assigns a valuation rating of 0 / 10 to STUDIO CITY INTERNATIONA-ADR (MSC). This can be considered as Overvalued.

Can you provide the profitability details for STUDIO CITY INTERNATIONA-ADR?

STUDIO CITY INTERNATIONA-ADR (MSC) has a profitability rating of 1 / 10.

Can you provide the financial health for MSC stock?

The financial health rating of STUDIO CITY INTERNATIONA-ADR (MSC) is 1 / 10.

STUDIO CITY INTERNATIONA-ADR (MSC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

STUDIO CITY INTERNATIONA-ADR / MSC FAQ

What is the fundamental rating for MSC stock?

What is the valuation status of STUDIO CITY INTERNATIONA-ADR (MSC) stock?

Can you provide the profitability details for STUDIO CITY INTERNATIONA-ADR?

Can you provide the financial health for MSC stock?